Nanopharmaceutics

Nanopharmaceutics, Inc. is a clinical-stage specialty pharmaceutical company developing oral, topical, and injectable products for cancer, central nervous system (CNS) diseases, and infectious diseases. Leveraging its expertise in nanoparticle and fine particle formulations, which are specifically designed to enhance the delivery of challenging BCS Class II and IV drugs, Nanopharmaceutics focuses on formulation development aimed at improving drug absorption and stability.